These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2551584)

  • 21. Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase.
    Murata T; Isomura H; Yamashita Y; Toyama S; Sato Y; Nakayama S; Kudoh A; Iwahori S; Kanda T; Tsurumi T
    Virology; 2009 Jun; 389(1-2):75-81. PubMed ID: 19427010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome.
    Shirakata M; Imadome KI; Hirai K
    Virology; 1999 Oct; 263(1):42-54. PubMed ID: 10544081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unchanged expression of Epstein-Barr virus-determined nuclear antigen-1 in productive virus cycle.
    Nováková Z; Krchnák V; Roubal J
    Acta Virol; 1988 Jul; 32(4):349-52. PubMed ID: 2903640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
    Dyson OF; Pagano JS; Whitehurst CB
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role for a region of helically unstable DNA within the Epstein-Barr virus latent cycle origin of DNA replication oriP in origin function.
    Polonskaya Z; Benham CJ; Hearing J
    Virology; 2004 Oct; 328(2):282-91. PubMed ID: 15464848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms in Epstein-Barr virus infection and replication].
    Sairenji T; Mori T; Ohashi M; Horie K; Touge C
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():543-6. PubMed ID: 16615531
    [No Abstract]   [Full Text] [Related]  

  • 27. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma.
    Heston L; Rabson M; Brown N; Miller G
    Nature; 1982 Jan; 295(5845):160-3. PubMed ID: 6276755
    [No Abstract]   [Full Text] [Related]  

  • 30. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
    Schepers A; Pich D; Hammerschmidt W
    Virology; 1996 Jun; 220(2):367-76. PubMed ID: 8661388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.
    Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.
    Gahn TA; Schildkraut CL
    Cell; 1989 Aug; 58(3):527-35. PubMed ID: 2547525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies.
    Gutierrez MI; Bhatia K; Magrath I
    Leuk Res; 1993 Mar; 17(3):285-9. PubMed ID: 8383779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the uracil-DNA glycosylase activity of Epstein-Barr virus BKRF3 and its role in lytic viral DNA replication.
    Lu CC; Huang HT; Wang JT; Slupphaug G; Li TK; Wu MC; Chen YC; Lee CP; Chen MR
    J Virol; 2007 Feb; 81(3):1195-208. PubMed ID: 17108049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Epstein-Barr virus in latently infected cell lines.
    Luka J
    J Virol Methods; 1988 Sep; 21(1-4):223-7. PubMed ID: 2846613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Origins of bidirectional replication of Epstein-Barr virus: models for understanding mammalian origins of DNA synthesis.
    Wang J; Sugden B
    J Cell Biochem; 2005 Feb; 94(2):247-56. PubMed ID: 15546145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis.
    Sugden B; Warren N
    Mol Biol Med; 1988 Apr; 5(2):85-94. PubMed ID: 2840551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus silver anniversary.
    Lancet; 1989 May; 1(8648):1171-3. PubMed ID: 2566738
    [No Abstract]   [Full Text] [Related]  

  • 40. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
    Kudoh A; Fujita M; Kiyono T; Kuzushima K; Sugaya Y; Izuta S; Nishiyama Y; Tsurumi T
    J Virol; 2003 Jan; 77(2):851-61. PubMed ID: 12502801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.